Phase III CHARM Trial Evaluates Accelerated Radiation Therapy for Patients Undergoing Breast Reconstruction After Mastectomy
Using an accelerated course of radiation therapy “does not increase complications” in patients who undergo breast reconstruction after a mastectomy, according to results from the phase III RT CHARM trial presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting. The study is the “first multi-institutional international study to show that a shorter course of post-mastectomy radiation, combined with breast reconstruction, is safe and effective,” according to ASTRO officials. Matthew M. Poppe, MD, FASTRO, the principal investigator of the trial and a professor of radiation oncology at the University of ...
Advertisement

Latest News

Advertisement
Advertisement
Our Contributors

Expert Interviews

Conference Highlights

Cecilia BrownMPN | October 3, 2024
The panel used an iterative process to create patient-facing and provider-facing consensus statements across 7 domains.
Read More
Cecilia BrownMultiple Myeloma | October 2, 2024
New research highlights the need for “early and equitable” integration of palliative care for patients with myeloma.
Cecilia BrownGU Cancer | September 27, 2024
The study investigators say the 5-year survival rate "dramatically exceeds historical standards."
Cecilia BrownGU Cancer | September 25, 2024
Learn what a team found when they implemented a pre-appointment electronic PRO measure for patients with prostate cancer.

Network Websites